Manufacturers Life Insurance Company, The Galapagos Nv Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$37.4 - $44.52 $455,868 - $542,654	-12,189 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$37.44 - $46.51 $250,436 - $311,105	6,689 Added 121.62%	12,189 $540,000
Q4 2022 Feb 13, 2023	BUY	$37.44 - $46.51 $250,436 - $311,105	6,689 Added 121.62%	12,189 $540,000
Q3 2022 Aug 11, 2023	BUY	$42.27 - $57.6 $232,485 - $316,800	5,500 New	5,500 $234,000
Q3 2022 Nov 03, 2022	BUY	$42.27 - $57.6 $232,485 - $316,800	5,500 New	5,500 $232,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.